Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum IM Cannabis Corp C.IMCC

Alternate Symbol(s):  IMCC

IM Cannabis Corp. is a Canada-based international cannabis company that provides cannabis products to medical patients in Israel and Germany. The Company's ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging proprietary data and patient insights. The Company also operates medical... see more

CSE:IMCC - Post Discussion

IM Cannabis Corp > Q2 Revenues
View:
Post by WeeblesWobble on Jul 23, 2021 11:06am

Q2 Revenues

Seems Q2 revenues will fall short of Rock's expectations:

https://ca.finance.yahoo.com/news/im-cannabis-provides-german-operations-124000191.html
Comment by RockMaschine on Jul 23, 2021 12:21pm
Don't deflect onto me, they were the company's own projections which they explained in that news release are due to the slower availability of product for the German distribution arm. Still lots of growth to occur and I'm looking to end of year when Q3 and 4 will start to push closer to $20 million.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities